Fragile X syndrome and model organisms: Identifying potential routes of therapeutic intervention

DMM Disease Models and Mechanisms

Volumn 3, Issue 11-12, 2010, Pages 693-700

  Bhogal, Balpreet ^a   Jongens, Thomas A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 AMINOBUTYRIC ACID; ALPHA METHYL 4 PHOSPHONOPHENYLGLYCINE; ALPHA METHYL 4 TETRAZOLYLPHENYLGLYCINE; AMINOBENZTROPINE; BACLOFEN; CREATININE; DOMINANT NEGATIVE PAK; FENOBAM; FRAGILE X MENTAL RETARDATION PROTEIN; GENE PRODUCT; LITHIUM; METABOTROPIC RECEPTOR ANTAGONIST; NIPECOTIC ACID; PILOCARPINE; STX 107; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DROSOPHILA MELANOGASTER; EXPERIMENTAL MOUSE; FRAGILE X SYNDROME; GENE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; TREATMENT INDICATION;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MICE; MOLECULAR TARGETED THERAPY;

EID: 78649247396     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.002006     Document Type: Review

References (99)

1. Ashley, C. T., Wilkinson, K. D., Reines, D. and Warren, S. T. (1993a). FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262, 563-566.
2. Ashley, C. T., Sutcliffe, J. S., Kunst, C. B., Leiner, H. A., Eichler, E. E., Nelson, D. L. and Warren, S. T. (1993b). Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat. Genet. 4, 244-251.
3. Bakker, C. E., Verheij, C., Willemsen, R., Vanderhelm, R., Oerlemans, F., Vermey, M., Bygrave, A., Hoogeveen, A. T., Oostra, B. A., Reyniers, E. et al. (1994). Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell 78, 23-33.
4. Bear, M. F., Huber, K. M. and Warren, S. T. (2004). The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370-377.
5. Bechara, E. G., Didiot, M. C., Melko, M., Davidovic, L., Bensaid, M., Martin, P., Castets, M., Pognonec, P., Khandjian, E. W., Moine, H. et al. (2009). A novel function for fragile X mental retardation protein in translational activation. PLoS Biol. 7, e16.
6. Berry-Kravis, E., Abrams, L., Coffey, S. M., Hall, D. A., Greco, C., Gane, L. W., Grigsby, J., Bourgeois, J. A., Finucane, B., Jacquemont, S. et al. (2007). Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov. Disord. 22, 2018-2030.
7. Berry-Kravis, E., Sumis, A., Hervey, C., Nelson, M., Porges, S. W., Weng, N., Weiler, I. J. and Greenough, W. T. (2008). Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J. Dev. Behav. Pediatr. 29, 293-302.
8. Berry-Kravis, E., Hessl, D., Coffey, S., Hervey, C., Schneider, A., Yuhas, J., Hutchison, J., Snape, M., Tranfaglia, M., Nguyen, D. V. et al. (2009). A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J. Med. Genet. 46, 266-271.
9. Bolduc, F. V., Bell, K., Cox, H., Broadie, K. S. and Tully, T. (2008). Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat. Neurosci. 11, 1143-1145.
10. Bontekoe, C. J., McIlwain, K. L., Nieuwenhuizen, I. M., Yuva-Paylor, L. A., Nellis, A., Willemsen, R., Fang, Z., Kirkpatrick, L., Bakker, C. E., McAninch, R. et al. (2002). Knockout mouse model for Fxr2: a model for mental retardation. Hum. Mol. Genet. 11, 487-498.
11. Brennan, F. X., Albeck, D. S. and Paylor, R. (2006). Fmr1 knockout mice are impaired in a leverpress escape/avoidance task. Genes Brain Behav. 5, 467-471.
12. Brown, V., Small, K., Lakkis, L., Feng, Y., Gunter, C., Wilkinson, K. D. and Warren, S. T. (1998). Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J. Biol. Chem. 273, 15521-15527.
13. Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D. et al. (2001). Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477-487. (Pubitemid 33152783)
14. Carroll, R. C., Lissin, D. V., von Zastrow, M., Nicoll, R. A. and Malenka, R. C. (1999). Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures. Nat. Neurosci. 2, 454-460.
15. Caudy, A. A., Myers, M., Hannon, G. J. and Hammond, S. M. (2002). Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 16, 2491-2496.
16. Caudy, A. A., Ketting, R. F., Hammond, S. M., Denli, A. M., Bathoorn, A. M., Tops, B. B., Silva, J. M., Myers, M. M., Hannon, G. J. and Plasterk, R. H. (2003). A micrococcal nuclease homologue in RNAi effector complexes. Nature 425, 411-414.
17. Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G. et al. (2008). Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biol. Psychiatry 63, 963-973.
18. Chang, S., Bray, S. M., Li, Z., Zarnescu, D. C., He, C., Jin, P. and Warren, S. T. (2008). Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat. Chem. Biol. 4, 256-263.
19. Chen, L. and Toth, M. (2001). Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103, 1043-1050.
20. Coffee, L. R., Jr, Tessier, C. R., Woodruff, E. A., III and Broadie, K. (2010). Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P. Dis. Model. Mech. 3, 471-485.
21. Corbin, F., Bouillon, M., Fortin, A., Morin, S., Rousseau, F. and Khandjian, E. W. (1997). The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6, 1465-1472.
22. Curia, G., Papouin, T., Seguela, P. and Avoli, M. (2009). Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb. Cortex 19, 1515-1520.
23. D'Hulst, C., De Geest, N., Reeve, S. P., Van Dam, D., De Deyn, P. P., Hassan, B. A. and Kooy, R. F. (2006). Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res. 1121, 238-245.
24. Darnell, J. C., Jensen, K. B., Jin, P., Brown, V., Warren, S. T. and Darnell, R. B. (2001). Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489-499.
25. Darnell, J. C., Fraser, C. E., Mostovetsky, O., Stefani, G., Jones, T. A., Eddy, S. R. and Darnell, R. B. (2005). Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev. 19, 903-918.
26. Desai, N. S., Casimiro, T. M., Gruber, S. M. and Vanderklish, P. W. (2006). Early postnatal plasticity in neocortex of Fmr1 knockout mice. J. Neurophysiol. 96, 1734-1745.
27. Devys, D., Lutz, Y., Rouyer, N., Bellocq, J. P. and Mandel, J. L. (1993). The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat. Genet. 4, 335-340.
28. Dockendorff, T. C., Su, H. S., McBride, S. M., Yang, Z., Choi, C. H., Siwicki, K. K., Sehgal, A. and Jongens, T. A. (2002). Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 34, 973-984.
29. Dolen, G., Osterweil, E., Rao, B. S., Smith, G. B., Auerbach, B. D., Chattarji, S. and Bear, M. F. (2007). Correction of fragile X syndrome in mice. Neuron 56, 955-962.
30. Eadie, B. D., Zhang, W. N., Boehme, F., Gil-Mohapel, J., Kainer, L., Simpson, J. M. and Christie, B. R. (2009). Fmr1 knockout mice show reduced anxiety and alterations in neurogenesis that are specific to the ventral dentate gyrus. Neurobiol. Dis. 36, 361-373.
31. Eberhart, D. E., Malter, H. E., Feng, Y. and Warren, S. T. (1996). The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5, 1083-1091.
32. Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C. F., Seeburg, D. P., Batterton, M. N., Tada, T., Dolan, B. M., Sharp, P. A. and Sheng, M. (2010). Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65, 373-384.
33. El Idrissi, A., Ding, X. H., Scalia, J., Trenkner, E., Brown, W. T. and Dobkin, C. (2005). Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. Neurosci. Lett. 377, 141-146.
34. El Idrissi, A., Boukarrou, L., Dokin, C. and Brown, W. T. (2009). Taurine improves congestive functions in a mouse model of fragile X syndrome. Adv. Exp. Med. Biol. 643, 191-198.
35. Feng, Y., Absher, D., Eberhart, D. E., Brown, V., Malter, H. E. and Warren, S. T. (1997). FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1, 109-118.
36. Galvez, R. and Greenough, W. T. (2005). Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am. J. Med. Genet. A 135, 155-160.
37. Godfraind, J. M., Reyniers, E., De Boulle, K., D'Hooge, R., De Deyn, P. P., Bakker, C. E., Oostra, B. A., Kooy, R. F. and Willems, P. J. (1996). Long-term potentiation in the hippocampus of fragile X knockout mice. Am. J. Med. Genet. 64, 246-251.
38. Hagerman, P. J. (2008). The fragile X prevalence paradox. J. Med. Genet. 45, 498-499.
39. Hagerman, R. J. (2002). Medical follow-up and pharmacotherapy. In Fragile X Syndrome: Diagnosis, Treatment and Research, 3rd edn. (ed. R. J. Hagerman and P. J. Hagerman) pp. 251-262. Baltimore, MD: The Johns Hopkins University Press.
40. Hagerman, R. J., Hall, D. A., Coffey, S., Leehey, M., Bourgeois, J., Gould, J., Zhang, L., Seritan, A., Berry-Kravis, E., Olichney, J. et al. (2008). Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin. Interv. Aging 3, 251-262.
41. Hayashi, M. L., Choi, S. Y., Rao, B. S., Jung, H. Y., Lee, H. K., Zhang, D., Chattarji, S., Kirkwood, A. and Tonegawa, S. (2004). Altered cortical synaptic morphology and impaired memory consolidation in forebrain-specific dominant-negative PAK transgenic mice. Neuron 42, 773-787. (Pubitemid 38748791)
42. Hayashi, M. L., Rao, B. S., Seo, J. S., Choi, H. S., Dolan, B. M., Choi, S. Y., Chattarji, S. and Tonegawa, S. (2007). Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc. Natl. Acad. Sci. USA 104, 11489-11494.
43. Hou, L., Antion, M. D., Hu, D., Spencer, C. M., Paylor, R. and Klann, E. (2006). Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51, 441-454.
44. Huber, K. M., Kayser, M. S. and Bear, M. F. (2000). Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288, 1254-1257.
45. Huber, K. M., Gallagher, S. M., Warren, S. T. and Bear, M. F. (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. USA 99, 7746-7750.
46. Inlow, J. K. and Restifo, L. L. (2004). Molecular and comparative genetics of mental retardation. Genetics 166, 835-881.
47. Inoue, S., Shimoda, M., Nishinokubi, I., Siomi, M. C., Okamura, M., Nakamura, A., Kobayashi, S., Ishida, N. and Siomi, H. (2002). A role for the Drosophila fragile X-related gene in circadian output. Curr. Biol. 12, 1331-1335.
48. Ishizuka, A., Siomi, M. C. and Siomi, H. (2002). A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev. 16, 2497-2508.
49. Jacquemont, S., Hagerman, R. J., Hagerman, P. J. and Leehey, M. A. (2007). Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol. 6, 45-55.
50. Jin, P., Zarnescu, D. C., Ceman, S., Nakamoto, M., Mowrey, J., Jongens, T. A., Nelson, D. L., Moses, K. and Warren, S. T. (2004). Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat. Neurosci. 7, 113-117.
51. Kelleher, R. J., 3rd and Bear, M. F. (2008). The autistic neuron: troubled translation? Cell 135, 401-406.
52. Kesler, S. R., Lightbody, A. A. and Reiss, A. L. (2009). Cholinergic dysfunction in fragile X syndrome and potential intervention: a preliminary 1H MRS study. Am. J. Med. Genet. A 149, 403-407.
53. Khandjian, E. W., Corbin, F., Woerly, S. and Rousseau, F. (1996). The fragile X mental retardation protein is associated with ribosomes. Nat. Genet. 12, 91-93.
54. Laggerbauer, B., Ostareck, D., Keidel, E. M., Ostareck- Lederer, A. and Fischer, U. (2001). Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10, 329-338.
55. Larson, J., Jessen, R. E., Kim, D., Fine, A. K. and du Hoffmann, J. (2005). Age-dependent and selective impairment of long-term potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein. J. Neurosci. 25, 9460-9469.
56. Lee, A., Li, W., Xu, K., Bogert, B. A., Su, K. and Gao, F. B. (2003). Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1. Development 130, 5543-5552.
57. Li, J., Pelletier, M. R., Perez Velazquez, J. L. and Carlen, P. L. (2002). Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol. Cell. Neurosci. 19, 138-151.
58. Li, Z., Zhang, Y., Ku, L., Wilkinson, K. D., Warren, S. T. and Feng, Y. (2001). The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29, 2276-2283. (Pubitemid 32514930)
59. McBride, S. M., Giuliani, G., Choi, C., Krause, P., Correale, D., Watson, K., Baker, G. and Siwicki, K. K. (1999). Mushroom body ablation impairs short-term memory and long-term memory of courtship conditioning in Drosophila melanogaster. Neuron 24, 967-977.
60. McBride, S. M., Choi, C. H., Wang, Y., Liebelt, D., Braunstein, E., Ferreiro, D., Sehgal, A., Siwicki, K. K., Dockendorff, T. C., Nguyen, H. T. et al. (2005). Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45, 753-764.
61. Michel, C. I., Kraft, R. and Restifo, L. L. (2004). Defective neuronal development in the mushroom bodies of Drosophila fragile X mental retardation 1 mutants. J. Neurosci. 24, 5798-5809.
62. Mientjes, E. J., Willemsen, R., Kirkpatrick, L. L., Nieuwenhuizen, I. M., Hoogeveen-Westerveld, M., Verweij, M., Reis, S., Bardoni, B., Hoogeveen, A. T., Oostra, B. A. et al. (2004). Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo. Hum. Mol. Genet. 13, 1291-1302.
63. Miyashiro, K. Y., Beckel-Mitchener, A., Purk, T. P., Becker, K. G., Barret, T., Liu, L., Carbonetto, S., Weiler, I. J., Greenough, W. T. and Eberwine, J. (2003). RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37, 417-431.
64. Moldin, S. O. (2005). Understanding Fragile X syndrome: molecular, cellular and genomic neuroscience at the crossroads. Genes Brain Behav. 4, 337-340.
65. Monzo, K., Papoulas, O., Cantin, G. T., Wang, Y., Yates, J. R., 3rd and Sisson, J. C. (2006). Fragile X mental retardation protein controls trailer hitch expression and cleavage furrow formation in Drosophila embryos. Proc. Natl. Acad. Sci. USA 103, 18160-18165.
66. Morales, J., Hiesinger, P. R., Schroeder, A. J., Kume, K., Verstreken, P., Jackson, F. R., Nelson, D. L. and Hassan, B. A. (2002). Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 34, 961-972.
67. Napoli, I., Mercaldo, V., Boyl, P. P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., Mohr, E., Massimi, M., Falconi, M. et al. (2008). The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134, 1042-1054.
68. Nimchinsky, E. A., Oberlander, A. M. and Svoboda, K. (2001). Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 21, 5139-5146.
69. Oberle, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boue, J., Bertheas, M. F. and Mandel, J. L. (1991). Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097-1102.
70. Pacey, L. K., Heximer, S. P. and Hampson, D. R. (2009). Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures. Mol. Pharmacol. 76, 18-24.
71. Pan, L., Woodruff, E., 3rd, Liang, P. and Broadie, K. (2008). Mechanistic relationships between Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A signaling. Mol. Cell. Neurosci. 37, 747-760.
72. Paradee, W., Melikian, H. E., Rasmussen, D. L., Kenneson, A., Conn, P. J. and Warren, S. T. (1999). Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94, 185-192.
73. Pascual, A. and Preat, T. (2001). Localization of longterm memory within the Drosophila mushroom body. Science 294, 1115-1117. (Pubitemid 33041869)
74. Pepper, A. S., Beerman, R. W., Bhogal, B. and Jongens, T. A. (2009). Argonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects. PLoS ONE 4, e7618.
75. Reeve, S. P., Bassetto, L., Genova, G. K., Kleyner, Y., Leyssen, M., Jackson, F. R. and Hassan, B. A. (2005). The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain. Curr. Biol. 15, 1156-1163.
76. Repicky, S. and Broadie, K. (2009). Metabotropic glutamate receptor-mediated use-dependent down-regulation of synaptic excitability involves the fragile X mental retardation protein. J Neurophysiol. 101, 672-687.
77. Schaeffer, C., Bardoni, B., Mandel, J. L., Ehresmann, B., Ehresmann, C. and Moine, H. (2001). The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20, 4803-4813.
78. Selby, L., Zhang, C. and Sun, Q. Q. (2007). Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci. Lett. 412, 227-232.
79. Siomi, H., Siomi, M. C., Nussbaum, R. L. and Dreyfuss, G. (1993). The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74, 291-298. (Pubitemid 23221705)
80. Slegtenhorst-Eegdeman, K. E., de Rooij, D. G., Verhoef-Post, M., van de Kant, H. J., Bakker, C. E., Oostra, B. A., Grootegoed, J. A. and Themmen, A. P. (1998). Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development. Endocrinology 139, 156-162.
81. Snyder, E. M., Philpot, B. D., Huber, K. M., Dong, X., Fallon, J. R. and Bear, M. F. (2001). Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat. Neurosci. 4, 1079-1085.
82. Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D. and Warren, S. T. (1992). DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1, 397-400.
83. Toniolo, D. (2006). X-linked premature ovarian failure: a complex disease. Curr. Opin. Genet. Dev. 16, 293-300.
84. Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F. P. et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914.
85. Volk, L. J., Pfeiffer, B. E., Gibson, J. R. and Huber, K. M. (2007). Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation. J. Neurosci. 27, 11624-11634.
86. Walsh, C. A., Morrow, E. M. and Rubenstein, J. L. (2008). Autism and brain development. Cell 135, 396-400.
87. Wan, L., Dockendorff, T. C., Jongens, T. A. and Dreyfuss, G. (2000). Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol. Cell. Biol. 20, 8536-8547.
88. Weiler, I. J. and Greenough, W. T. (1999). Synaptic synthesis of the Fragile X protein: possible involvement in synapse maturation and elimination. Am. J. Med. Genet. 83, 248-252.
89. Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J. and Greenough, W. T. (1997). Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. USA 94, 5395-5400.
90. Wilson, B. M. and Cox, C. L. (2007). Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Proc. Natl. Acad. Sci. USA 104, 2454-2459.
91. Xu, K., Bogert, B. A., Li, W., Su, K., Lee, A. and Gao, F. B. (2004). The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein pickpocket1. Curr. Biol. 14, 1025-1034.
92. Xu, X. L., Li, Y., Wang, F. and Gao, F. B. (2008). The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila. J. Neurosci. 28, 11883-11889.
93. Yan, Q. J., Rammal, M., Tranfaglia, M. and Bauchwitz, R. P. (2005). Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49, 1053-1066. (Pubitemid 41503304)
94. Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B. and Bagni, C. (2003). The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112, 317-327.
95. Zalfa, F., Eleuteri, B., Dickson, K. S., Mercaldo, V., De Rubeis, S., di Penta, A., Tabolacci, E., Chiurazzi, P., Neri, G., Grant, S. G. et al. (2007). A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat. Neurosci. 10, 578-587.
96. Zars, T., Fischer, M., Schulz, R. and Heisenberg, M. (2000). Localization of a short-term memory in Drosophila. Science 288, 672-675.
97. Zhang, Y. Q., Bailey, A. M., Matthies, H. J., Renden, R. B., Smith, M. A., Speese, S. D., Rubin, G. M. and Broadie, K. (2001). Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107, 591-603.
98. Zhang, Y. Q., Matthies, H. J., Mancuso, J., Andrews, H. K., Woodruff, E., 3rd, Friedman, D. and Broadie, K. (2004). The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis. Dev. Biol. 270, 290-307.
99. Zhao, M. G., Toyoda, H., Ko, S. W., Ding, H. K., Wu, L. J. and Zhuo, M. (2005). Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J. Neurosci. 25, 7385-7392.